全文获取类型
收费全文 | 7136篇 |
免费 | 355篇 |
国内免费 | 55篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 117篇 |
妇产科学 | 80篇 |
基础医学 | 1340篇 |
口腔科学 | 96篇 |
临床医学 | 595篇 |
内科学 | 1113篇 |
皮肤病学 | 164篇 |
神经病学 | 885篇 |
特种医学 | 247篇 |
外科学 | 960篇 |
综合类 | 41篇 |
一般理论 | 2篇 |
预防医学 | 358篇 |
眼科学 | 239篇 |
药学 | 635篇 |
中国医学 | 10篇 |
肿瘤学 | 621篇 |
出版年
2023年 | 22篇 |
2022年 | 41篇 |
2021年 | 97篇 |
2020年 | 51篇 |
2019年 | 87篇 |
2018年 | 85篇 |
2017年 | 62篇 |
2016年 | 90篇 |
2015年 | 131篇 |
2014年 | 157篇 |
2013年 | 272篇 |
2012年 | 384篇 |
2011年 | 421篇 |
2010年 | 272篇 |
2009年 | 257篇 |
2008年 | 453篇 |
2007年 | 527篇 |
2006年 | 492篇 |
2005年 | 567篇 |
2004年 | 476篇 |
2003年 | 529篇 |
2002年 | 477篇 |
2001年 | 82篇 |
2000年 | 63篇 |
1999年 | 96篇 |
1998年 | 135篇 |
1997年 | 92篇 |
1996年 | 80篇 |
1995年 | 66篇 |
1994年 | 62篇 |
1993年 | 75篇 |
1992年 | 35篇 |
1991年 | 60篇 |
1990年 | 38篇 |
1989年 | 46篇 |
1988年 | 24篇 |
1987年 | 24篇 |
1986年 | 24篇 |
1985年 | 22篇 |
1984年 | 24篇 |
1983年 | 26篇 |
1982年 | 33篇 |
1981年 | 31篇 |
1980年 | 28篇 |
1979年 | 18篇 |
1978年 | 21篇 |
1977年 | 29篇 |
1976年 | 19篇 |
1975年 | 19篇 |
1974年 | 21篇 |
排序方式: 共有7546条查询结果,搜索用时 15 毫秒
111.
Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates. 总被引:2,自引:0,他引:2
Pawel Surowiak Verena Materna Malgorzata Drag-Zalesinska Andrzej Wojnar Irina Kaplenko Marek Spaczyński Manfred Dietel Maciej Zabel Hermann Lage 《International journal of gynecological pathology》2006,25(2):131-139
High cytoplasmic expression of maspin was described in ovarian cancers of shorter survival rates. Until now, no relationship has been described between expression of maspin and sensitivity to cisplatin in ovarian cancers. This study aimed at examining the relationship between expression of maspin, detected by immunohistochemistry and clinical response to cisplatin in ovarian cancer cases as well as the in vitro sensitivity to cisplatin of 11 ovarian cancer cell lines. The analyzes were performed on 73 samples of ovarian cancer and on A2780P, A2780RCIS, CAOV-3, EFO 21, EFO 27, ES-2, Mdah 2774, OAW 42, OVCAR-3, PA-1, and SKOV-3 ovarian cancer cells. Cytoplasmic maspin expression in studied cells significantly correlated with cisplatin sensitivity. A significantly shorter overall survival and progression-free survival was associated with lower cytoplasmic maspin expression at first-look laparotomies and nuclear maspin expression and secondary cytoreductions. Higher nuclear maspin at first-look laparotomies expression was specific for cases of complete response. In the study, the elevated expression of maspin was shown to be typical for cisplatin-sensitive ovarian cancers. 相似文献
112.
Katrin Lamszus Marc A Brockmann Carmen Eckerich Peter Bohlen Chad May Ulrich Mangold Regina Fillbrandt Manfred Westphal 《Clinical cancer research》2005,11(13):4934-4940
PURPOSE: Inhibition of angiogenesis can influence tumor cell invasion and metastasis. We previously showed that blockade of vascular endothelial growth factor receptor-2 (VEGFR-2) with the monoclonal antibody DC101 inhibited intracerebral glioblastoma growth but caused increased tumor cell invasion along the preexistent vasculature. In the present study, we attempted to inhibit glioma cell invasion using a monoclonal antibody against the epidermal growth factor receptor (EGFR), which in the context of human glioblastomas, has been implicated in tumor cell invasion. In addition, we analyzed whether blockade of vascular endothelial (VE)-cadherin as a different antiangiogenic target could also inhibit glioblastoma angiogenesis and growth. EXPERIMENTAL DESIGNS: Nude mice who received intracerebral glioblastoma xenografts were treated using monoclonal antibodies against VEGFR-2 (DC101), EGFR (C225), and VE-cadherin (E4G10) either alone or in different combinations. RESULTS: Increased tumor cell invasion provoked by DC101 monotherapy was inhibited by 50% to 66% by combined treatment with C225 and DC101. C225 inhibited glioblastoma cell migration in vitro, but had no effect on the volume of the main tumor mass or on tumor cell proliferation or apoptosis in vivo, either alone or in combination with DC101. The anti-VE-cadherin monoclonal antibody E4G10 was a weaker inhibitor of tumor angiogenesis and growth than DC101, and also caused a weaker increase in tumor cell invasion. CONCLUSIONS: Inhibition of angiogenesis achieved by blocking either VEGFR-2 or VE-cadherin can cause increased glioma cell invasion in an orthotopic model. Increased tumor cell invasion induced by potent inhibition of angiogenesis with DC101 could be inhibited by simultaneous blockade of EGFR. 相似文献
113.
Gunter von Minckwitz Sebastian Harder Sascha Hövelmann Elke Jäger Salah-Eddin Al-Batran Sibylle Loibl Akin Atmaca Christian Cimpoiasu Antje Neumann Aklil Abera Alexander Knuth Manfred Kaufmann Dirk Jäger Alexander B Maurer Winfried S Wels 《Breast cancer research : BCR》2005,8(1):1-2
Overcoming dendritic cell (DC) dysfunction is a prerequisite for successful active immunotherapy against breast cancer. CD40 ligand (CD40L), a key molecule in the interface between T-lymphocytes and DCs, seems to be instrumental in achieving that goal. Commenting on our data that CD40L protects circulating DCs from apoptosis induced by breast tumor products, Lenahan and Avigan highlighted the potential of CD40L for immunotherapy. We expand on that argument by pointing to additional findings that CD40L not only rescues genuine DCs but also functionally improves populations of immature antigen-presenting cells that fill the DC compartment in patients with breast cancer. 相似文献
114.
115.
Athanasia Apsemidou Kerstin Rauwolf Athanasios Tragiannidis Angela Brentrup Manfred Schiborr Karsten Becker Martina Ahlmann Andreas H. Groll 《Pediatric blood & cancer》2019,66(4)
Bartonella henselae, the causative agent of cat‐scratch disease, has been recognized to be responsible for a broad range of clinical syndromes. We report the case of a patient with disseminated B. henselae infection mimicking Langerhans cell histiocytosis at presentation and its successful management with neurosurgery, prolonged antibacterial therapy, and observation. 相似文献
116.
Romi Goldschlager Hedley Roth Jarryd Solomon Scott Robson Jessica Green Sarah Green Manfred Spanger Robyn Gunn Peter Cameron 《Emergency radiology》2014,21(4):367-372
Current literature suggests that a large proportion of chest X-rays (CXRs) performed in emergency department (ED) patients with chest pain and suspected acute coronary syndrome (ACS) are unnecessary. The Canadian ACS Guidelines aim to guide clinicians in the appropriate use of CXR within this patient population. This study determined the prevalence of clinically significant CXR abnormalities and assessed the utility of the guidelines in a population of ED patients with chest pain and suspected ACS. Included in the study were participants over the age of 18 who presented to an Australian metropolitan ED, over a 1-year period, with a primary complaint of chest pain and who had a CXR and troponin level ordered in the ED (N?=?760). We retrospectively compared their radiographic findings with their recommendations for CXR according to the ACS Guidelines. We found that 12 % of the participants had a clinically significant chest X-ray. The guidelines had a sensitivity of 80 % (95 % CI 0.70–0.87) and specificity of 50 % (95 % CI 0.47–0.54). The positive predictive value was 18 % (95 % CI 0.15–0.22) with a 95 % negative predictive value (95 % CI 0.92–0.97). Had the ACS guidelines been applied to our patient population, the number of CXR performed would have been reduced by 47 %. This study suggests that the ACS Guidelines has the potential to reduce the numbers of unnecessary CXR performed in ED patients. However, this would come at the expense of missing a minority of significant CXR abnormalities. 相似文献
117.
118.
119.